MedTrace Logo

Adequacy of Prostate-Specific Antigen (PSA) Requests

NCT03968692 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1410

Last updated 2019-06-13

No results posted yet for this study

Summary

Objectives.

The primary aim of this study is to evaluate the characteristics of the determination of PSA for the early detection of prostate cancer or in the presence of symptoms, in general practice in two health departments of the Valencian Community (Spain).

Specific objectives:

* To describe the PSA determinations that are performed in clinical practice, with the exception of patients with prostate cancer or who are being followed for previous high PSA values.
* To study the adequacy of PSA requests according to the available recommendations, considering sociodemographic and clinical aspects of the patient, such as the time interval since the last PSA test.

The investigators will randomly select patients from the Health Departments 17 and 19, in the Valencian Community (Spain) with a PSA request from Primary health centres.

Conditions

  • Prostate-Specific Antigen

Interventions

DIAGNOSTIC_TEST

Prostate-Specific Antigen test

Prostate-Specific Antigen (PSA) test as opportunistic screening or in the presence of symptoms

Sponsors & Collaborators

  • Hospital Universitario San Juan de Alicante

    collaborator OTHER

  • Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

    collaborator OTHER

  • Universidad Miguel Hernandez de Elche

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-09-30
Completion
2019-12-31
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03968692 on ClinicalTrials.gov